633
Views
13
CrossRef citations to date
0
Altmetric
Review

Immune checkpoint inhibition for the treatment of renal cell carcinoma

, , , & ORCID Icon
Pages 83-94 | Received 05 May 2019, Accepted 04 Oct 2019, Published online: 13 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Parmida Sadat Pezeshki & Nima Rezaei. (2021) Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opinion on Biological Therapy 21:9, pages 1173-1179.
Read now
Viktoria Stühler, Jan Moritz Maas, Simon Walz, Arnulf Stenzl & Jens Bedke. (2020) An evaluation of avelumab for the treatment of genitourinary tumors. Expert Opinion on Biological Therapy 20:9, pages 971-979.
Read now

Articles from other publishers (11)

Nikolas Dovrolis, Hector Katifelis, Stamatiki Grammatikaki, Roubini Zakopoulou, Aristotelis Bamias, Michalis V. Karamouzis, Kyriakos Souliotis & Maria Gazouli. (2023) Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma. Cancers 15:23, pages 5637.
Crossref
Naomi B. Haas, Yan Song, Jaqueline Willemann Rogerio, Su Zhang, Christopher Carley, JingJing Zhu, Rituparna Bhattacharya, James Signorovitch & Murali Sundaram. (2023) Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results‐Medicare datac. International Journal of Urology 30:3, pages 272-279.
Crossref
Georges Mjaess, Aya Karam, Fouad Aoun, Simone Albisinni & Thierry Roumeguère. (2021) Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature. Cancer 128:1, pages 14-19.
Crossref
Pia Adam, Stefan Kircher, Iuliu Sbiera, Viktoria Florentine Koehler, Elke Berg, Thomas Knösel, Benjamin Sandner, Wiebke Kristin Fenske, Hendrik Bläker, Constantin Smaxwil, Andreas Zielke, Bence Sipos, Stephanie Allelein, Matthias Schott, Christine Dierks, Christine Spitzweg, Martin Fassnacht & Matthias Kroiss. (2021) FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale. Frontiers in Endocrinology 12.
Crossref
Alessandro Rizzo, Veronica Mollica, Matteo Santoni, Matteo Rosellini, Andrea Marchetti, Angela Dalia Ricci, Giada Grilli, Alba Greco, Rodolfo Montironi, Andrea Ardizzoni & Francesco Massari. (2021) Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis. Immunotherapy 13:9, pages 783-793.
Crossref
Rafieh Bagherifar, Seyed Hossein Kiaie, Zahra Hatami, Armin Ahmadi, Abdolvahid Sadeghnejad, Behzad Baradaran, Reza Jafari & Yousef Javadzadeh. (2021) Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives. Journal of Nanobiotechnology 19:1.
Crossref
Jakub Rosik, Bartosz Szostak, Filip Machaj & Andrzej Pawlik. (2021) The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences 22:6, pages 3081.
Crossref
Fengjun Sun, Zhuo Chen, Pu Yao, Bangbi Weng, Zhirui Liu & Lin Cheng. (2021) Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in Pharmacology 12.
Crossref
Ilaria Zizzari, Alessandra Di Filippo, Fabio Scirocchi, Francesca Di Pietro, Hassan Rahimi, Alessio Ugolini, Simone Scagnoli, Pamela Vernocchi, Federica Del Chierico, Lorenza Putignani, Aurelia Rughetti, Paolo Marchetti, Marianna Nuti, Andrea Botticelli & Chiara Napoletano. (2020) Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients. Journal of Personalized Medicine 10:4, pages 208.
Crossref
Alexander V. Gopanenko, Ekaterina N. Kosobokova & Vyacheslav S. Kosorukov. (2020) Main Strategies for the Identification of Neoantigens. Cancers 12:10, pages 2879.
Crossref
Maria-Elisabeth Goebeler & Ralf C. Bargou. (2020) T cell-engaging therapies — BiTEs and beyond. Nature Reviews Clinical Oncology 17:7, pages 418-434.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.